Paul Hopper

Paul Hopper

Net worth: 1 M $ as of 30/07/2026

70 year
Health Technology
Commercial Services
Finance

Profile

Paul A. Hopper founded Prescient Therapeutics Ltd. in 1986, where he worked as Non-Executive Director from 2014 to 2020, Imugene Ltd. in 2012, where he is working as Executive Chairman from 2014, Radiopharm Theranostics Ltd. in 2021, where he is working as Executive Chairman from 2021, and various other companies.
Mr. Hopper also founded Pathway Oncology Pty Ltd., Glioblast Pty Ltd., Polynoma LLC, where he worked as Lead Director, and various other companies.
Mr. Hopper also currently works at Vaxinia Pty Ltd., as Chairman, Cappello Group, Inc., as Managing Director from 2015, Biolife Science Ltd., as Director, and various other companies.
Mr. Hopper also formerly worked at CAQ Holdings Ltd., as Executive Chairman in 2008, Viralytics Pty Ltd., as Executive Chairman from 2012 to 2013, Botanix Pharmaceuticals Ltd., as Executive Chairman in 2007, and various other companies.
Mr. Hopper received his undergraduate degree from The University of New South Wales.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/07/2025 12,614,263 ( 2.58% ) 753 072 $ 30/07/2026
17/03/2026 54,150,000 ( 1.38% ) 532 295 $ 30/07/2026

Paul Hopper active positions

CompaniesPositionStart
IMUGENE LIMITED Founder 30/10/2012
RADIOPHARM THERANOSTICS LIMITED Founder 31/12/2020
Chairman -
Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 31/10/2005
President -

Former positions of Paul Hopper

CompaniesPositionEnd
CHIMERIC THERAPEUTICS LIMITED Founder 24/11/2025
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Paul Hopper's experience

Training of Paul Hopper

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

33

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies33

Commercial Services

Finance

Finance

Health Technology

Finance

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Commercial Services

Finance

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

C19 Therapeutics Pty Ltd.

Bioscience Oncology Pty Ltd.

Health Services

Health Technology